Larvol Delta - sNDA-for-AXS05-for-the-treatment-of-Alzheimers-disease-agitation-granted-Priority-Review-with-PDUFA-target-action-date-of-April-30-2026

Auvelity (bupropion/dextromethorphan) - Axsome Therap

https://www.manilatimes.net/2026/02/23/tmt-newswire/globenewswire/axsome-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update/2282872

Feb 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next